Abstract
IntroductionThere have been several studies showing the effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs) for anxious depression. We aimed to summarise the evidence and evaluate the methodological quality regarding the effectiveness and safety of NSAIDs for anxious depression from systematic reviews/meta-analyses (SRs/MAs).Methods and analysisTwo researchers searched seven databases for SRs/MAs, which are randomised controlled trials on NSAIDs for anxious depression. Two investigators used the Assessment System for Evaluating Methodological Quality 2, the Risk of Bias in Systematic reviews tool, the list of preferred reporting items for SRs/MAs and the Grading of Recommendations, Assessment, Development and Evaluation system to assess the included SRs/MAs.Ethics and disseminationThe findings of the study will be disseminated through peer-reviewed journals, and national and international conference presentations.
Funder
National Natural Science Foundation of China
Reference16 articles.
1. World Health Organization . Depression fact sheet. World Health Organization, 2016. Available: http://www.who.int/mediacentre/factsheets/fs369/en/
2. Emotional roles of Mono-Aminergic neurotransmitters in major depressive disorder and anxiety disorders;Liu;Front Psychol,2018
3. The relevance of 'mixed anxiety and depression' as a diagnostic category in clinical practice;Möller;Eur Arch Psychiatry Clin Neurosci,2016
4. Common and specific alterations of amygdala subregions in major depressive disorder with and without anxiety: a combined structural and resting-state functional MRI study;Li;Front Hum Neurosci,2021
5. Major depressive disorder and anxiety disorders from the glial perspective: Etiological mechanisms, intervention and monitoring
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献